Biomaterials and cells for cardiac tissue engineering: Current choices

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cardiovascular Research

Background:

• Cardiac diseases pose a growing health risk, necessitating innovative therapeutic strategies.
• Current treatments for infarcted cardiac cells are limited, driving the need for tissue engineering solutions.

Purpose of the Study:

• To provide a comprehensive review of cell sources and biomaterials for cardiac tissue engineering.
• To highlight the importance of biocompatibility and scaffold criteria for successful cardiac regeneration.

Main Methods:

• Review of existing literature on cell sources for cardiac tissue engineering.
• Analysis of various scaffold types and their properties.
• Discussion of cell-biomaterial interactions and fabrication techniques.

Main Results:

• Identified key cell sources including cardiomyocytes, stem cells, fibroblasts, and parthenogenetic cells.
• Outlined essential scaffold criteria: non-immunogenicity, biodegradability, and native tissue mimicry.
• Described scaffold types such as hydrogels, prefabricated matrices, decellularized scaffolds, and cell sheets.

Conclusions:

• Successful cardiac tissue engineering relies on the judicious selection of cell sources and biomaterials.
• Advancements in scaffold fabrication enable the production of viable tissue-engineered cardiac products.
• This field holds significant promise for developing stable and sustainable treatments for cardiac ailments.